ICC International Cannabis Corp (CNSX:WLRD.U) (FRA:8K51) (OTCMKTS:WLDCF) CEO David Shpilt joins Midas Letter to discuss the differentiating factors of the business within the competitive cannabis marketplace. ICC, through its subsidiaries, has operating assets and is developing platforms for cultivation, extraction, formulation and distribution across the globe and primarily in Europe. The main focus of the company will be the the medical European market as nations within the continent are regulated to medical standards only. The company is currently in the process of developing business units to become fully vertically integrated within that European market. Currently, ICC export dried flower out of Canada and import into Germany under compliance with EU GMP standards. Mr. Shpilt states the company will "be selling in Denmark, and then shortly in the UK." Further to ICC's European focus, the company will supply New Zealand's NUBU Pharmaceuticals with a portfolio of full-spectrum pharmaceutical THC/CBD products. Watch the full interview to learn about all the company's plans in the near-future as they look to become revenue-positive.

************************

Check out our website:
https://midasletter.com

************************

SUBSCRIBE to our YouTube:
http://bit.ly/MidasLetterYoutube

SUBSCRIBE to our 2nd YouTube Channel - Midas Letter Clips:
https://bit.ly/2rtQzgy

SUBSCRIBE to our Newsletter:
http://bit.ly/MidasLetterNewsletter

Download Our Podcast on iTunes:
http://bit.ly/MidasLetterPodcast

************************

Follow Us on Twitter:
http://bit.ly/MidasLetterTwitter

Like Us on Instagram:
http://bit.ly/MidasLetterInsta

Like Us on Facebook:
http://bit.ly/MidasLetterFacebook

************************

#WeedStocks
#MidasLetter